Press release
Multiple Sclerosis Pipeline Drugs 2024 | TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, Ge
Find out more about Multiple Sclerosis treatment drugs @ Drugs for Multiple Sclerosis Treatment [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from Multiple Sclerosis Pipeline Report
* August 2024:- Hoffmann-La Roche- A Single Arm, Open Label Multicentre Extension Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Multiple Sclerosis Previously Enrolled In A F. Hoffmann-La Roche Sponsored Ocrelizumab Phase IIIb/IV Clinical Trials. This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who were previously enrolled in a F. Hoffmann-La Roche (Roche) sponsored ocrelizumab phase IIIb/IV trial (i.e. the Parent, P-trial).
* August 2024:- Novartis Pharmaceuticals- Open-Label Rater-Blind Randomized Multi-Center Parallel-Arm Active- Comparator Study to Assess the Efficacy and Tolerability of Ofatumumab 20mg SC Monthly vs. First Line DMT - Physician's Choice in the Treatment of Newly Diagnosed RMS. This study will compare ofatumumab vs. European approved platform first line self-administered disease modifying therapy (DMT) in newly diagnosed MS patients
* DelveInsight's Multiple Sclerosis pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for Multiple Sclerosis treatment.
* The leading Multiple Sclerosis Companies working in the market include TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others.
* Promising Multiple Sclerosis Therapies in the various stages of development include 11C-BMS-986196, ofatumumab, Fingolimod, Siponimod, elezanumab, Alemtuzumab, Tecfidera, and others
Request a sample and discover the recent advances in Multiple Sclerosis treatment drugs @ Multiple Sclerosis Pipeline Outlook Report [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Multiple Sclerosis Emerging Drugs Profile
* Ublituximab: TG Therapeutics
* IMU-838: Immunic
* ATA188: Atara Biotherapeutics
* ANK-700: ANOKION
Multiple Sclerosis Therapeutics Assessment
There are approx. 100+ key Multiple Sclerosis companies which are developing the therapies for Multiple sclerosis. The Multiple Sclerosis companies which have their Multiple sclerosis drug candidates in the most advanced stage, i.e. preregistration include, TG Therapeutics.
DelveInsight's Multiple Sclerosis pipeline report covers around 100+ products under different phases of clinical development like
* Late stage products (Phase III)
* Mid-stage products (Phase II)
* Early-stage product (Phase I) along with the details of
* Pre-clinical and Discovery stage candidates
* Discontinued & Inactive candidates
* Route of Administration
Learn more about the emerging Multiple Sclerosis pipeline therapies @ Multiple Sclerosis Clinical Trials [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Multiple sclerosis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.
* Oral
* Parenteral
* Intravenous
* Subcutaneous
* Topical.
* Molecule Type
Multiple Sclerosis Products have been categorized under various Molecule types such as
* Monoclonal Antibody
* Peptides
* Polymer
* Small molecule
* Gene therapy
* Product Type
Multiple Sclerosis Companies
TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others
Dive deep into rich insights for new drugs for Multiple Sclerosis Treatment, visit @ Multiple Sclerosis Drugs [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Multiple Sclerosis Pipeline Report
* Coverage- Global
* Multiple Sclerosis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Multiple Sclerosis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
* Multiple Sclerosis Companies- TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, and others
* Multiple Sclerosis Therapies- 11C-BMS-986196, ofatumumab, Fingolimod, Siponimod, elezanumab, Alemtuzumab, Tecfidera, and others
For further information on the Multiple Sclerosis Pipeline Therapeutics, reach out @ Multiple Sclerosis Treatment Drugs [https://www.delveinsight.com/sample-request/multiple-sclerosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
* Introduction
* Executive Summary
* Multiple sclerosis: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Multiple sclerosis - DelveInsight's Analytical Perspective
* Late Stage Products (Preregistration)
* Ublituximab: TG Therapeutics
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* EHP 101: Emerald Health Pharmaceuticals
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* ASLAN 003: ASLAN Pharmaceuticals
* Drug profiles in the detailed report.....
* Preclinical and Discovery Stage Products
* Lucid MS: FSD Pharma
* Drug profiles in the detailed report.....
* Inactive Products
* Multiple sclerosis Key Companies
* Multiple sclerosis Key Products
* Multiple sclerosis- Unmet Needs
* Multiple sclerosis- Market Drivers and Barriers
* Multiple sclerosis- Future Perspectives and Conclusion
* Multiple sclerosis Analyst Views
* Multiple sclerosis Key Companies
* Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=multiple-sclerosis-pipeline-drugs-2024-tg-therapeutics-immunic-atara-biotherapeutics-anokion-imstem-biotechnology-merck-serono-cinnagen-immune-response-biopharma-inc-clene-nanomedicine-ge]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple Sclerosis Pipeline Drugs 2024 | TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, Ge here
News-ID: 3620170 • Views: …
More Releases from ABNewswire
Chronic Venous Insufficiency Market Growth Anticipated by 2034 | Companies inclu …
Several factors are expected to accelerate the growth of the Chronic Venous Insufficiency market during the forecast period (2023-2034). Increased awareness about available treatments, rising disease prevalence, and heightened disease awareness are key drivers.
In the Chronic Venous Insufficiency (CVI) market, significant growth is anticipated from 2019 to 2032, as detailed in the latest report, "Chronic Venous Insufficiency Market Insights, Epidemiology and Market Forecast 2032 [https://www.delveinsight.com/report-store/chronic-venous-insufficiency-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" by DelveInsight. This expected surge…
Gene Therapies For Cardiomyopathies Market Growth Anticipated by 2032 | Companie …
Gene Therapies For Cardiomyopathies Market Growth is expected due to increased interest from companies in developing new gene therapies, advancements in diagnostic techniques, and the anticipated introduction of emerging therapies during the forecast period.
According to the latest report titled "Gene Therapies for Cardiomyopathies Market Insights, Epidemiology, and Market Forecast 2032 [https://www.delveinsight.com/report-store/gene-therapies-for-cardiomyopathies-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" from DelveInsight, the Gene Therapies for Cardiomyopathies market is projected to experience significant growth from 2019 to 2032. This…
Cascade Web Solutions: Elevating Digital Presence for Local Businesses in the Pa …
Cascade Web Solutions, based in Tri-Cities, WA, provides custom web development and local SEO services using advanced technologies like Next.js and React. They create high-performance websites that enhance user experience and search engine rankings. Known for affordability and transparent pricing, they offer tailored solutions to boost online visibility for businesses. With a client-centric approach and proven results, Cascade Web Solutions helps businesses achieve their digital goals.
Tri-Cities, WA - Cascade Web…
Transforming Cancer Therapy Stocks to Watch In The Oncology Sector (OSTX, ATNM, …
In oncology, the relentless drive for innovation is forging new paths in cancer treatment. The field is rapidly evolving with advances in targeted therapies, immunotherapies, and novel technologies, each promising to reshape patient outcomes. Let's explore some standout companies that are leading the charge in this transformative era of cancer care with their cutting-edge approaches and pioneering therapies.
OS Therapies Inc. (NYSEAmerican: OSTX) is gaining attention in the biotech space for…
More Releases for Multiple
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)…
Multiple Sclerosis Therapeutics Market – Increasing prevalence of multiple scl …
Multiple Sclerosis Therapeutics Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Multiple Sclerosis Therapeutics Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis.
This comprehensive…
Global Multiple Sclerosis Market Size, Global Multiple Sclerosis Market Share, G …
The Global Multiple Sclerosis Market Size is majorly driven by the factors such as rising number of consolidations between the market players for exploring the untapped market opportunity across the world.
Request for Sample of This Research Report @ https://bit.ly/2Nh6b4d
Top Key Player:-
Hoffmann-La Roche Ltd.
Bayer Healthcare AG
Teva Pharmaceuticals
GlaxoSmithKline
AbbVie Inc.
Sonafi Pasteur
Pfizer Inc.
Merck & Company
Novartis AG
AB Science
Opexa
Multiple Sclerosis (MS) is a disease in which the insulating covers of nerves and spinal cord are…
Multiple Ion Beam Microscopes Market- Multiple Ion Beam Microscopes Have Huge Ap …
An ion beam is a kind of charged particle beam which consists of ions. With the advancement of nanotechnology new and advanced fabrication techniques are required which helps in production of functional features in much smaller scales. Advanced techniques are being used for applications in material science which uses image surfaces producing different features in a nanoscale. Gas field ion source technology has the capability of combining helium and neon…
Smart Antenna Market Report 2018: Segmentation by Type (Switched Beam Smart Ante …
Global Smart Antenna market research report provides company profile for Cobham Antenna Systems(Suffolk, United Kingdom), Intel Corp.( Santa Clara, California, United States), Samsung Electronics CoLtd. ( Seoul, South Korea), ArrayComm LLC ( California, United States), Alcatel-Lucent International Holdings Inc.( Paris, France), Motorola Solutions Inc.( Illinois, the U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017,…
Thermoseal Group Multiple Award Winners
For the second year in a row, Thermoseal Group is the winner of the coveted Glass and Glazing Industry’s G-Award for ‘Component Supplier of the Year’ as announced at the prestigious Gala Dinner held at the Hilton on Park Lane Hotel in London on Friday 18 November 2016.
This was a great day for Thermoseal Group who were also announced winners at two other awards events held that day…
